» Articles » PMID: 32886112

Cardiac Arrhythmia Prevention in Ischemia and Reperfusion by Low-Dose Dietary Fish Oil Supplementation in Rats

Overview
Journal J Nutr
Publisher Elsevier
Date 2020 Sep 5
PMID 32886112
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Supplementing animal diets with fish oil increases myocardial omega-3 polyunsaturated fatty acids [ω-3 (n-3) PUFA], lowers heart rate, and prevents malignant cardiac arrhythmias. In contrast to epidemiological reports, results of some human clinical trials and of unphysiologically high doses employed in animal studies call into question the application of dietary ω-3 PUFA for cardioprotection.

Objective: This study tested the hypothesis that low ω-3 PUFA dietary thresholds for myocardial incorporation in rats, equivalent in dose to what humans derive from eating fish, can reduce heart rate and arrhythmia vulnerability.

Methods: Male Sprague-Dawley rats (12-15 wk old) were fed isoenergetic diets containing 10% fat for 4-5 wk. The control diet (CON) contained 5.5% beef tallow, 2.5% sunflower seed oil, and 2% olive oil. Fish oil diets contained high-DHA tuna oil, exchanged for olive oil: 0.31% [fish oil group 1 (FO1)] (human equivalent EPA + DHA 570 mg/d); 1.25% [fish oil group 2 (FO2)] (equivalent EPA + DHA 2.3 g/d). Anaesthetized rats (pentobarbital, 60 mg/kg intraperitoneally) were subjected in vivo to 15-min cardiac ischemia by left coronary artery occlusion and then reperfusion, with arrhythmias detected by electrocardiogram.

Results: Fish oil dose dependently modulated myocardial membrane fatty acids (DHA mean ± SEM: CON, 5.0 ± 0.2%; FO1, 13.1 ± 0.9%; FO2, 18.3 ± 0.4%; n = 4-5; P-trend < 0.001 ANOVA); resting heart rate (CON, 453 ± 6; FO1, 432 ± 4; FO2, 422 ± 5 bpm; n = 15-18; P-trend < 0.001); reduced ventricular fibrillation (VF) (CON, 89%; FO1, 60%; P = 0.052; FO2, 50%; n = 15-18; P = 0.013 chi square); and total arrhythmia severity (arrhythmia score: CON, 6.1 ± 0.4; FO1, 4.6 ± 0.5; FO2, 3.1 ± 0.7; n = 15-18; P-trend < 0.01) during ischemia and reperfusion (VF: Con, 86%; FO1, 22% P = 0.011; FO2, 8% P = 0.001; n = 7-12); (arrhythmia score: CON, 4.6 ± 0.3; FO1, 3.1 ± 0.3; FO2, 1.3 ± 0.3; n = 7-12; P-trend < 0.001).

Conclusions: Ventricular arrhythmias were prevented and heart rate was slowed by lower ω-3 PUFA intake in rats than previously reported, equivalent to human fish consumption and associated with increased myocardial DHA. The efficacy of low-dose fish oil demonstrates biological plausibility for nutritional ω-3 fatty acid-mediated cardioprotection and suggests that effectiveness in human clinical trials may be obscured by failure to exclude fish eaters.

Citing Articles

Emulsification and stabilisation technologies used for the inclusion of lipophilic functional ingredients in food systems.

Henao-Ardila A, Quintanilla-Carvajal M, Moreno F Heliyon. 2024; 10(11):e32150.

PMID: 38873677 PMC: 11170136. DOI: 10.1016/j.heliyon.2024.e32150.


Transcriptomic analysis reveals the lipid metabolism-related gene regulatory characteristics and potential therapeutic agents for myocardial ischemia-reperfusion injury.

Wu J, Cai H, Hu X, Wu W Front Cardiovasc Med. 2024; 11:1281429.

PMID: 38347951 PMC: 10859419. DOI: 10.3389/fcvm.2024.1281429.


Intake of marine and plant-derived n-3 fatty acids and development of atherosclerotic cardiovascular disease in the Danish Diet, Cancer and Health cohort.

Bork C, Lundbye-Christensen S, Veno S, Lasota A, Tjonneland A, Schmidt E Eur J Nutr. 2023; 62(3):1389-1401.

PMID: 36592188 DOI: 10.1007/s00394-022-03081-w.


Examining dietary behaviours, diet quality, motives and supplementation use in physically active individuals following vegetarian-based eating patterns.

Craddock J, Neale E, Peoples G, Probst Y Nutr Bull. 2022; 47(4):473-487.

PMID: 36352440 PMC: 10098725. DOI: 10.1111/nbu.12592.


The Effects of Fish Oil on Cardiovascular Diseases: Systematical Evaluation and Recent Advance.

Liao J, Xiong Q, Yin Y, Ling Z, Chen S Front Cardiovasc Med. 2022; 8:802306.

PMID: 35071366 PMC: 8767101. DOI: 10.3389/fcvm.2021.802306.